Executive Bios

Noven Directors & Officers

Directors
	SIDNEY BRAGINSKY Mr. Braginsky is President and Chief Executive Officer of Atropos Technology Inc. (consulting and venture capital) and Chairman of Digilab LLC (molecular spectroscopy). From 1970 through 1999, Mr. Braginsky served Olympus America, Inc. in a variety of roles, most recently as President and Chief Operating Officer. Mr. Braginsky serves on the board of directors of Mediscience (optical biopsy development), Diomed Holdings (laser technology), Geneva Acquisition Corporation (acquisitions) and Electro-Optical Sciences, Inc. (surgical and medical instruments).
	JOHN G. CLARKSON, M.D. Dr. Clarkson is the Executive Director of the American Board of Ophthalmology and the Dean Emeritus and Professor of Ophthalmology, Miller School of Medicine at the University of Miami. From 1995 to 2006, he served as Professor and Senior Vice President for Medical Affairs and Dean, University of Miami School of Medicine. Dr. Clarkson serves as a director of the American Board of Medical Specialties and as a trustee for the Evelyn F. McKnight Brain Research Foundation.
	DONALD A. DENKHAUS Mr. Denkhaus has, since January 2004, served as the exeutive chairman of TM Systems, LLC (international language services). Since 2005, he has also served as President and Chief Executive Officer of Integrity Risk Advisors (consulting). Mr. Denkhaus was a partner with Arthur Andersen LLP from 1980 to 2002 and served as Arthur Andersen’s audit practice director responsible for Florida and Puerto Rico from 1999 to 2002. For a one-year period in 2002 and 2003, Mr. Denkhaus was employed as a principal with Ernst & Young LLP where he provided audit services and assisted in the transition of Arthur Andersen audit clients and personnel to Ernst & Young.
	PEDRO P. GRANADILLO Mr. Granadillo was employed by Eli Lilly and Company (pharmaceuticals) from 1970 until 2004. From 1998 to 2004, he served as Eli Lilly’s Senior Vice President overseeing manufacturing, quality and human resources and from 1993 to 1998, he served as Vice President of Human Resources. Mr. Granadillo serves on the board of directors of First Indiana Corporation (banking), First Indiana Bank, N.A. (banking) and Haemonetics Corporation (medical devices).
	PHILLIP M. SATOW Mr. Satow was appointed to Noven’s Board of Directors in August 2007 upon the closing of Noven’s acquisition of JDS Pharmaceuticals, LLC. Mr. Satow was JDS’s co-founder and served as its Chief Executive Officer from inception in August 2004 through completion of the acquisition. After 15 years with Pfizer and three years as Vice President and General Manager of the Carter Wallace pharmaceutical business, Mr. Satow served as Executive Vice President of Forest Laboratories and President of its Forest Pharmaceuticals subsidiary. He established the marketing and sales departments at Forest, which he led for 14 years through the launch of Forest’s highly-successful antidepressant Celexa^®.
	ROBERT G. SAVAGE Mr. Savage has been the President of Strategic Imagery LLC (pharmaceutical consulting) since May 2003. He served as Group Vice President and President – General Therapeutics & Inflammation Business of Pharmacia Corporation from 2002 until its acquisition by Pfizer, Inc. in 2003. From 1996 through 2001, Mr. Savage served Johnson & Johnson in a variety of roles, most recently as Chairman of Johnson & Johnson’s Pharmaceutical Group. From 1985 to 1996, he served Roche Holding AG in a variety of marketing, business development and operations positions, most recently as Vice President – Marketing, Hoffmann-La Roche, Inc. Mr. Savage serves as the non-executive chairman of EpiCept Corporation (pharmaceuticals) and as the presiding director of The Medicines Company, Inc. (pharmaceuticals).
	ROBERT C. STRAUSS Mr. Strauss is Chairman of the Board of Directors, and has been President and Chief Executive Officer and a Director of Noven since December 1997. From March 1997 to July 1997, he served as President and Chief Operating Officer and a Director of IVAX Corporation (pharmaceuticals). From 1983 to 1997, he served in various executive positions with Cordis Corporation, most recently as its Chairman of the Board, President and Chief Executive Officer.
	WAYNE P. YETTER Mr. Yetter has been Chief Executive Officer of Verispan LLC (health care information) since September 2005. From November 2004 to September 2005, he served as the Chief Executive Officer of Odyssey Pharmaceuticals, Inc., the specialty pharmaceutical division of Pliva d.d. From 2003 to 2005, he served on the Advisory Board of Alterity Partners (mergers and acquisition advisory firm). From September 2000 to June 2003, Mr. Yetter served as Chairman and Chief Executive Officer of Synavant Inc. (pharmaceutical marketing/technology services). From 1999 to 2000, Mr. Yetter served as Chief Operating Officer at IMS Health, Inc. (information services for the healthcare industry). From 1997 to 1999, he served as President and Chief Executive Officer of Novartis Pharmaceuticals Corporation (pharmaceuticals). From 1991 to 1994, Mr. Yetter served as General Manager and then President of Astra Merck, a division of Merck & Co. From 1994 to 1997, he served as President and Chief Executive Officer of Astra Merck, Inc. (pharmaceuticals). Mr. Yetter serves on the board of directors of Matria Healthcare, Inc. (disease management), EpiCept Corporation (pharmaceuticals), Alteon, Inc. (pharmaceuticals) and HAPC, Inc. (healthcare acquisitions).

Officers
	ROBERT C. STRAUSS Mr. Strauss is Chairman of the Board of Directors, and has been President and Chief Executive Officer and a Director of Noven since December 1997. From March 1997 to July 1997, he served as President and Chief Operating Officer and a Director of IVAX Corporation (pharmaceuticals). From 1983 to 1997, he served in various executive positions with Cordis Corporation, most recently as its Chairman of the Board, President and Chief Executive Officer.
	DR. EDUARDO G. ABRAO Dr. Eduardo G. Abrao joined Noven in September 2003 as Vice President – Clinical Development & Chief Medical Officer. Prior to joining Noven, he served as Vice President of Regulatory Affairs & Drug Safety at Berlex Laboratories. From 1996 to 2002, he served Otsuka America Pharmaceutical in a number of leadership roles including Executive Vice President of Regulatory & Medical Affairs and as President & Chief Operating Officer. From 1989 to 1996, he served Marion Merrell Dow in various medical and clinical affairs roles.
	JEFFREY F. EISENBERG Jeffrey Eisenberg has been with Noven since November 1998 and serves as Senior Vice President – Strategic Alliances. From 1995 through 1998, he served as Associate General Counsel and then as Acting General Counsel of IVAX Corporation. Prior to IVAX, he was a lawyer in the corporate securities department of the law firm of Steel Hector & Davis.
	W. NEIL JONES Neil Jones has been with Noven since February 1997 and, since November 2000, has served as Vice President, Marketing and Sales. From 1981 through 1997, he served Ciba-Geigy Corporation in a variety of sales and marketing positions, most recently as Executive Director of Marketing.
	JUAN A. MANTELLE Juan Mantelle has been with Noven since March 1990 and, since June 2000, has served as Vice President and Chief Technical Officer. From December 1986 to March 1990, he served Paco Research Corp. as Manager – Product Development. From April 1983 to December 1986, he served Key Pharmaceuticals, Inc. as Senior Research Engineer where he helped develop some of the most successful transdermal products of that era.
	MICHAEL D. PRICE Michael Price joined Noven in November 2007 and serves as Vice President and Chief Financial Officer. He is a CPA with over 25 years of experience as a financial executive. From 1992 to 2006, he served as vice president, chief financial officer, treasurer and secretary for Bentley Pharmaceuticals, Inc., a NYSE listed specialty pharmaceuticals company. He also acted as a member of that company’s board of directors for nine years. Earlier in his career, he served as a senior executive with Carr Financial Group, and as vice president - finance with Premiere Group, Inc.
	CAROLYN DONALDSON Carolyn Donaldson has been with Noven since June 1998 and serves as Vice President – Human Resources. Prior to joining Noven, she served as Vice President of Human Resources for IVAX Corporation, a global branded and generic pharmaceutical company. From 1984 to 1997 she served as Executive Director – Human Resources at Cordis Corporation.
	RICHARD P. GILBERT Richard Gilbert joined Noven in December 2004 and serves as Vice President – Operations. He has over 22 years of experience in operations and manufacturing. Prior to joining Noven, he served as Vice President, Manufacturing Operations, at ConvaTec (a Bristol-Myers Squibb Company). Prior to ConvaTec, he held various senior roles at London International Group, LLC, The Tensar Corporation, and Richmond Technology.
	PAVAN HANDA Pavan Handa joined Noven in July 2002 and serves as Vice President – Business Development. He has over fifteen years of pharmaceutical industry experience in structuring and negotiating numerous agreements involving licensing, acquisitions, and strategic collaborations. Prior to joining Noven, he served as Senior Vice President, Business Development and Portfolio Management for Pharmacologics LLC, Director of Business Development and Marketing for Enzon Pharmaceuticals Inc., and Manager of Biomedical Business Development for Union Carbide Corporation.
	JAMES W. HARRIS, JR., PhD James W. Harris, Jr., PhD joined Noven in February 2004 and serves as Vice President – Quality Assurance & Quality Control. He has 20 years of experience in pharmaceutical quality control and quality assurance. Prior to joining Noven, he served as Executive Director, Regulatory Compliance for the American Red Cross and Executive Director, Regulatory Compliance for Berlex Laboratories, Inc. Previously, he served Otsuka America Pharmaceuticals in a number of senior executive roles including Senior Director, Information Technology & Quality Performance and Senior Director, Regulatory Compliance.
	JOSEPH C. JONES Joseph Jones has been with Noven since January 2001 and serves as Vice President – Corporate Affairs. He is principally responsible for analyst, investor and corporate communications as well as the company's governmental affairs function. Prior to joining Noven, he was President of SHD Strategic, L.C., a corporate communications consulting firm, and before that he served as Vice President, Investor Relations and Government Affairs for IVAX Corporation. Prior to joining IVAX, he was a partner in the corporate securities department of the law firm of Steel Hector & Davis.
	JEFF T. MIHM Jeff Mihm has been with Noven since 2003 and serves as Vice President and General Counsel. Prior to Noven, he served as Senior Corporate Counsel to Panamerican Beverages, Inc., the world's third largest Coca-Cola bottler at the time, and previously was a partner in the corporate securities department of the law firm of Steel Hector & Davis.
	DIANE M. BARRETT Diane Barrett retired as Chief Financial Officer of Noven effective November 2007. She will continue to serve as Vice President through year-end 2007,. From August 2000 to May 2003, she served as Vice President – Finance and Treasurer. She is a CPA with over 20 years finance and accounting experience. Prior to joining Noven, she served as Vice President and Chief Financial Officer of Bionumerik Pharmaceuticals, Inc., which specializes in mechanism-based drug discovery. Before Bionumerik, she served in various senior finance roles at Cordis Corporation, including Treasurer and Director of Finance.